DNA and Gene Cloning Services Market Poised for Rapid Expansion Driven by Advancements in Genetic Engineering, Biotechnology, and Gene Therapy Techniques

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2031"

The DNA and Gene Cloning Services Market Size is valued at USD 3.65 Billion in 2023 and is predicted to reach USD 14.88 Billion by the year 2031 at a 19.7 % CAGR during the forecast period for 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1357

The significant market companies are Bio-Techne, Curia, Eurofins, GenScript, MedGenome, Integrated DNA Technologies, Sino Biological, Syngene, Twist Bioscience, Thermo Fisher Scientific Inc., Charles River Laboratories, Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc., Bio-Rad, and other key players.

Key Developments in the Market
• In Jan 2021, Codex DNA and Pfizer signed an early access collaboration and licencing agreement, which will allow Pfizer to use CodexDNA's novel enzymatic DNA synthesis technology in its research and development of mRNA-based vaccines and biotherapies. Codex DNA will be responsible for further developing the technology.
• In May 2020, GenScript just launched a GMP single-strand and double-strand DNA service to aid in the growth of gene and cell therapies. The announcement highlights GenScript's commitment to assisting entire non-viral cell therapy development through the IND-enabling and clinical stages.
• In Dec 2020, Thermo Fisher increased its plasmid DNA manufacturing clinical and commercial capabilities. Commercialization of plasmid-based drugs and vaccines will be accelerated by the opening of a new cGMP facility in Carlsbad, California. The facility will also be able to generate large amounts of plasmid DNA, which is a crucial component of drugs used in DNA treatments. This growth builds on the business's ongoing commitment to providing cell and gene therapy services.
• In May 2020, Takara Bio announced a collaboration with AGC Biologics. The businesses will collaborate on a prophylactic DNA vaccine against COVID-19, with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine.

Gene synthesis and cloning are fundamental processes in various scientific applications. DNA amplification techniques such as subcloning and polymerase chain reaction (PCR) are commonly used for genetic cloning. DNA cloning, also known as recombinant DNA technology, involves combining genetic material from two different organisms into a single molecule, which is then introduced into a host organism to produce hybrid offspring.

DNA cloning is widely employed in protein production, gene analysis, and gene therapy. The process typically involves isolating the DNA from an organism, identifying a specific gene of interest, and then replicating or "cloning" that gene. The DNA cloning process incorporates steps such as plasmid DNA extraction, the use of restriction enzymes, and the introduction of the recombinant DNA into a living cell to facilitate multiplication. PCR is a key tool in the cloning process. In genetic engineering, "gene cloning" refers to the creation of synthetic copies of a gene for various research and therapeutic purposes.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

Gene cloning can be carried out through two primary methods: in vivo and in vitro. Many human genes have been successfully cloned in microorganisms such as E. coli or yeast, enabling the production of an unlimited supply of human proteins in vitro. Over 100 therapeutic drugs for human use are produced using cultured cells (E. coli, yeast, and mammalian cells) that have been modified with human genes. Gene cloning represents a groundbreaking technique in biotechnology, contributing significantly to advancements in human health, particularly in the treatment of chronic diseases, which has resulted in longer lifespans. Additionally, in agriculture, gene cloning is continually improving crop quality, enhancing nutritional value.

The market for DNA and gene cloning services is projected to experience steady growth in the coming years. This growth is driven by the increasing acceptance of gene therapies and the ongoing development of innovative DNA cloning technologies. The rise in research and development efforts, coupled with the growing demand for personalized medicine, is expected to further propel market expansion. Additionally, the market is supported by a favorable funding environment for gene synthesis and cloning services, technological advancements in cloning techniques, and the growing number of companies entering the sector.

Despite these positive trends, the gene synthesis market may face challenges in the form of a shortage of skilled professionals and lengthy, complex approval processes. However, advancements in technology, strategic partnerships, and acquisitions within the biomedical and healthcare sectors present significant opportunities. High levels of investment, funding, and collaborations for industrial growth are anticipated, particularly as North America focuses on integrating DNA and gene cloning into life sciences research, further stimulating market development.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1357

Market Segmentation:
Global DNA and Gene Cloning Services Market, by Type of Service Offered, 2023-2031 (Value US$ Mn)
• Custom Cloning
• Gene Synthesis
• Sub-cloning
• Others
Global DNA and Gene Cloning Services Market, by Type of Gene, 2023-2031 (Value US$ Mn)
• Complex Gene
• Standard Gene
• Others
Global DNA and Gene Cloning Services Market, by End-User Industry, 2023-2031 (Value US$ Mn)
• Academic and R&D
• Pharmaceutical and Biotechnology Companies
• Others
Global DNA and Gene Cloning Services Market, by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America DNA and Gene Cloning Services Market, by Country, 2023-2031 (Value US$ Mn)
• U.S.
• Canada
Europe DNA and Gene Cloning Services Market, by Country, 2023-2031 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific DNA and Gene Cloning Services Market, by Country, 2023-2031 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America DNA and Gene Cloning Services Market, by Country, 2023-2031 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa DNA and Gene Cloning Services Market, by Country, 2023-2031 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.